Rockwell Operating Cycle from 2010 to 2025

RMTI Stock  USD 1.35  0.05  3.57%   
Rockwell Medical's Operating Cycle is increasing with very volatile movements from year to year. Operating Cycle is predicted to flatten to 52.18. For the period between 2010 and 2025, Rockwell Medical, Operating Cycle quarterly trend regression had mean deviation of  2,927 and range of 25 K. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
54.92344898
Current Value
52.18
Quarterly Volatility
6.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 1.2 M or Total Revenue of 106.6 M, as well as many indicators such as Price To Sales Ratio of 0.59, Dividend Yield of 0.0 or PTB Ratio of 1.85. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Latest Rockwell Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Rockwell Medical over the last few years. It is Rockwell Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rockwell Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Very volatile
   Operating Cycle   
       Timeline  

Rockwell Operating Cycle Regression Statistics

Arithmetic Mean1,631
Geometric Mean96.37
Coefficient Of Variation382.95
Mean Deviation2,927
Median62.25
Standard Deviation6,244
Sample Variance39M
Range25K
R-Value0.08
Mean Square Error41.5M
R-Squared0.01
Significance0.76
Slope109.44
Total Sum of Squares584.8M

Rockwell Operating Cycle History

2025 52.18
2024 54.92
2023 76.19
2022 62.25
2021 57.97
2020 48.49
201925 K

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 54.92  52.18 

Currently Active Assets on Macroaxis

When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rockwell Medical. If investors know Rockwell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.03)
Revenue Per Share
3.268
Quarterly Revenue Growth
0.116
Return On Assets
0.0066
Return On Equity
(0.02)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rockwell Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rockwell Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rockwell Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.